Radiotherapy for solitary plasmacytoma and multiple myeloma;Strahlentherapie bei solitärem Plasmozytom und multiplem Myelom

Radiologe

Volumn 54, Issue 6, 2014, Pages 551-555

  Schmaus, M C ^a   Neuhof, D ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b MVZ Strahlentherapie und Nuklearmedizin Weinheim   (Germany)

Author keywords

Analgesia; Local control; Neurological symptoms; Radiotherapy; Recalcification

Indexed keywords

ADJUVANT THERAPY; HUMAN; MULTIPLE MYELOMA; PATHOLOGY; PLASMACYTOMA; PROCEDURES; RADIATION DOSE; RADIATION RESPONSE;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MULTIPLE MYELOMA; PLASMACYTOMA; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT;

EID: 84903590951     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-013-2630-2     Document Type: Article

References (18)

1. Bachar G, Goldstein D, Brown D et al (2008) Solitary extramedullary plasmacytoma of the head and neck-long term outcome analysis of 68 cases. Head Neck 30:1012-1019
2. Balducci M, Chiesa S, Manfrida S et al (2011) Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience. Strahlenther Onkol 187:114-119
3. Chao MW, Gibbs P, Wirth A et al (2005) Radiotherapy in the management of solitary extramedullary plasmacytoma. Intern Med J 35:211-215
4. Creach KM, Foote RL, Neben-Wittich MA, Kyle RA (2008) Radiotherapy for extra-medullary plasmacytoma of the head and neck. Int J Radiat Oncol Biol Phys 73:789-794
5. Frassica DA, Frassica FJ, Schray MF et al (1989) Solitary Plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys 16:43-48
6. Gerull S, Goerner M, Benner A et al (2005) Long-term outcome of non myeloablative allogenic transplantation in patients with high-risk multiple myeloma. Bone Marrow Transplant 36:963-969
7. Holland J, Trenkner DA, Wassermann TH, Fineberg B (1992) Plasmacystoma. Treatment results and conversion to myeloma. Cancer 69:1513-1517
8. Jyothirmayi R, Gangadharan VP, Nair MK, Rajan B (1997) Radiotherapy in the treatment of solitary plasmacytoma. Br J Radiol 70:511-516
9. Liebross RH, Ha CS, Cox JD et al (1999) Clinical course of solitary extramedullary plasmocytoma. Radiother Oncol 3:245-249
10. Mayr NA, Wen BC, Hussey DH et al (1990) The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol 17:293-303
11. Mose S, Pfitzner D, Rahn A et al (2000) Role of radiotherapy in the treatment of multiple myeloma. Strahlenther Onkol 176:506-512
12. Ozsahin M, Tsang RW, Poortmans P et al (2006) Outcome and patterns of failure in solitary plasmacytoma: a multicenter rare cancer network study of 258 patients. Int J Radiat Oncol Biol Phys 1:210-217
13. Rades D, Hoskin PJ, Stalpers LJ et al (2006) Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. Int J Radiat Oncol Biol Phys 64:1452-1457
14. Stölting T, Knauerhase H, Klautke G et al (2008) Total and single doses influence the effectivness of radiotherapy in palliative treatment of plasmocytoma. Strahlenther Onkol 184:465-472
15. Tournier-Rangeard L, Lapeyre M, Graff-Caillaud P et al (2006) Radiotherapy for solitary extramedullary plasmocytoma in the head-and neck region: a dose greater then 45 Gy to the target volume improves the local control. Int J Radiat Oncol Biol Phys 64:1013-1017
16. Tsang RW, Gospodarowicz MK, Pintilie M et al (2001) Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys 50:113-120
17. Wilder RB, Ha CS, Cox JD et al (2002) Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmocytoma of bone. Cancer 94:1532-1537
18. Zentrum für Krebsregisterdaten, Robert-Koch-Institut. http://www.krebsdaten.de